{
    "title": "Individual feed for https://feeds.content.dowjones.io/public/rss/mw_topstories",
    "link": "https://feeds.content.dowjones.io/public/rss/mw_topstories",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-09-29T06:35:52.538423",
    "items": [
        {
            "title": "‘I thought she was honest’: My ex-wife hid stocks during our divorce. Can I sue her?",
            "link": "https://www.marketwatch.com/story/i-thought-she-was-honest-my-ex-wife-hid-her-stocks-during-our-divorce-can-i-sue-her-e75cab43?mod=mw_rss_topstories",
            "description": "“I have contacted her about it, but she refuses to answer my calls.”",
            "pubDate": "2025-09-29T11:23:00",
            "image_url": "https://images.mktw.net/im-37270843"
        },
        {
            "title": "Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating",
            "link": "https://www.marketwatch.com/story/morgan-stanley-expects-novo-nordisk-alzheimer-trial-to-fail-as-it-slashes-rating-98a9eeee?mod=mw_rss_topstories",
            "description": "Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, ...",
            "pubDate": "2025-09-29T10:36:00",
            "image_url": "https://images.mktw.net/im-86179513"
        },
        {
            "title": "Months after cancer drug trial, Merus agrees to be bought at 41% premium",
            "link": "https://www.marketwatch.com/story/months-after-cancer-drug-trial-merus-agrees-to-be-bought-at-41-premium-d7e87829?mod=mw_rss_topstories",
            "description": "Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.",
            "pubDate": "2025-09-29T10:34:00",
            "image_url": "https://images.mktw.net/im-34081553"
        },
        {
            "title": "‘He’s the breadwinner’: Does my husband take Social Security at 66 — or wait to get $800 extra at 70?",
            "link": "https://www.marketwatch.com/story/hes-the-breadwinner-does-my-husband-take-social-security-at-66-or-wait-to-get-800-extra-at-70-33b0ed85?mod=mw_rss_topstories",
            "description": "“My husband jokes that he will never be able to retire because we do not own a home.”",
            "pubDate": "2025-09-29T10:25:00",
            "image_url": "https://images.mktw.net/im-40443151"
        },
        {
            "title": "How the Trump administration is boosting stock buybacks",
            "link": "https://www.marketwatch.com/story/the-trump-effect-on-share-buybacks-theres-more-of-them-a8d93235?mod=mw_rss_topstories",
            "description": "Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.",
            "pubDate": "2025-09-29T10:22:00",
            "image_url": "https://images.mktw.net/im-79494160"
        }
    ]
}